CAPELLA THERAPEUTICS INC has a total of 29 patent applications. Its first patent ever was published in 2015. It filed its patents most often in United States, Taiwan and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are MYOKARDIA INC, JIKAI BIOSCIENCES INC and PROPELLON THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Taiwan | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Israel | 1 | |
#10 | Japan | 1 | |
#11 | Mexico | 1 | |
#12 | Russian Federation | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Long Yun | 27 |
#2 | Yun Long | 1 |
Publication | Filing date | Title |
---|---|---|
US2018273511A1 | Benzimidazoles for use in the treatment of cancer and inflammatory diseases | |
KR20170004969A | Benzimidazole derivatives as tyrosine kinase inhibitors for the treatment of cancer | |
CN106536506A | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer |